We found that CD24, PZP, COL1A1, COL1A2, LUM, VCAN, THBS2 and EPHA3 were potential biomarkers for distinguishing NAFLD/NASH. Here, CD24 is linked to metabolic dysfunction-associated steatohepatitis.